Research Article

The Efficacy and Safety of Traditional Chinese Medicine Tonifying-Shen (Kidney) Principle for Primary Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Table 2

Characteristics of the included studies.

No.Included studies (author, year)Age (years)Participants (experimental group/control group)InterventionOutcomesAdverse effects (experimental group/control)Treatment periods (months)Follow-up (months)
Control groupExperimental groupControl groupExperimental groupSecondary outcomesPrimary outcomes

1Zheng et al. [19], 201963.9 ± 2.8163.91 ± 2.8670/70Placebo capsules ± calcium carbonateBushen Yijing Fang ± calcium carbonateBMD of femoral neck; adverse effects9/836120
2Liu and Wang [42], 201656.15 ± 6.7755.86 ± 6.9262/62Alendronate sodium tablets ± calcium carbonate D3 tabletsErxian Bushen decoction ± acupuncture and moxibustion ± alendronate sodium tablets ± calcium carbonate D3 tabletsEffectiveness rate; BMD of femoral neck and lumbar spine6
3Xu et al. [43], 201863.90 ± 7.5965.16 ± 6.8232/31Calcium carbonate D3Thunder-fire moxibustion ± calcium carbonate D3VAS scores11
4Zhu et al. [20], 201264.9 ± 6.065.4 ± 6.361/61Calcium carbonate ± vitamin DXian Ling Gu Bao capsules ± calcium carbonate ± vitamin DBMD of femoral neck and lumbar spine; adverse effects11/111212
5Zhao and Yan [21], 201861.3 ± 4.162.1 ± 4.150/50Caltrate ± alpha D3 calciferolTraditional Chinese medicine prescription ± caltrate ± alpha D3 calciferolVAS scoresEffectiveness rate; BMD of lumbar spine (L2–4); adverse effects9/666
6Yuan et al. [22], 201440/40Alendronate ± calcium carbonate D3Chinese herbal medicine ± alendronate ± calcium carbonate D3Effectiveness rate6
7Huang [23], 201565.5 ± 1.665.7 ± 1.570/70Calcium carbonate D3 ± alfacalcidol soft capsulesBushenhuoxuetang ± calcium carbonate D3 ± alfacalcidol soft capsulesVAS scoresEffectiveness rate2
8Wu et al. [24], 200556.4 ± 4.655.6 ± 4.334/34Caltrate D600Xian Ling Gu Bao capsules ± caltrate D600BMD of femoral neck and lumbar spine12
9Liu et al. [25], 2011 (3)62.8 ± 5.9Liu 2011 (3): 63.7 ± 3.8; Liu 2011 (3): 61.8 ± 8.3A: 35/35; B: 35Calcichew D3 tabletsLiu 2011 (3): acupoint catgut embedding ± calcichew D3 tablets; Liu 2011 (3): Xianling Gubao capsules ± calcichew D3 tabletsVAS scoresEffectiveness rate; BMD of lumbar spine6
10Lu [47], 201462.14 ± 6.3460.84 ± 6.9525/22Calcium carbonate D3Acupoint catgut embedding ± calcium carbonate D3Effectiveness rate6
11Han et al. [44], 201167.39 ± 4. 0567.42 ± 3. 8930/30CaltrateShuganwenshentanyushuangjietang ± acupuncture and moxibustion ± caltrateEffectiveness rate6
12Liu et al. [26], 2011 (1)62.8 ± 5.9Liu 2011 (1): 63.7 ± 3.8; Liu 2011 (1): 61.8 ± 8.3A: 35/35 B: 35Calcichew D3 tabletsLiu 2011 (1): acupoint catgut embedding ± calcichew D3 tablets; Liu 2011 (1): Xian Ling Gu Bao capsules ± calcichew D3 tabletsTCM symptom integral0/0/46
13Peng et al. [48], 201735/35Calcichew D3 tablets ± alendronate sodium tabletsAcupoint catgut embedding ± calcichew D3 tablets ± alendronate sodium tabletsVAS scoresEffectiveness rate; BMD of lumbar spine3
14Peng et al. [49], 201845/45Calcichew D3 tablets ± alendronate sodium tabletsAcupoint catgut embedding ± calcichew D3 tablets ± alendronate sodium tabletsVAS scoresEffectiveness rate; BMD of lumbar spine33
15Zhong et al. [50], 201845/45Calcichew D3 tablets ± alendronate sodium tabletsAcupoint catgut embedding ± calcichew D3 tablets ± alendronate sodium tabletsVAS scoresEffectiveness rate; BMD of lumbar spine3
16Zou et al. [53], 201866.73 ± 3.7166.27 ± 3.1860/60Caltrate D tablets ± alendronate sodium tablets ± calcitriol soft capsulesAcupoint injection ± caltrate D tablets ± alendronate sodium tablets ± calcitriol soft capsulesEffectiveness rate; BMD of femoral neck and lumbar spine; adverse effects0/06
17Ma and Fan [45], 201868.43 ± 3.6868.56 ± 3.7942/42Calcium carbonate ± vitamin D tabletsBushenzhuanggutang ± acupuncture and moxibustion ± calcium carbonate ± vitamin D tabletsEffectiveness rate312
18Lin [51], 2006 (1)24/22Osteoform capsulesAcupoint catgut embedding ± osteoform capsulesBMD of femoral neck6
19Lin [52], 2006 (2)20/18Osteoform capsulesAcupoint catgut embedding ± osteoform capsulesBMD of femoral neck6
20Qi [27], 201675.42 ± 6.8376.5 ± 7.28100/100Caltrate DBushenqianggufang ± caltrate DEffectiveness rate; BMD of femoral neck and lumbar spine33
21Li et al. [28], 201775.4 ± 4.972.6 ± 5.530/30Calcitriol soft capsules ± caltrate D600Bushenjianpitang ± calcitriol soft capsules ± caltrate D600Effectiveness rate3
22Hu and Li [29], 2012155/145Caltrate D ± miacalcicShangkeyishenjianguwan ± caltrate D ± miacalcicBMD of lumbar spine36
23Liu and Gong [30], 201859.88 ± 7.4660.49 ± 7.2538/38Calcitriol soft capsules ± calcium carbonate D3 ± alendronate sodium tabletsBushenjianpihuoxuefang ± calcitriol soft capsules ± calcium carbonate D3 ± alendronate sodium tabletsEffectiveness rate; BMD of femoral neck and lumbar spine; adverse effects6/46
24Chen et al. [31], 201766.22 ± 11.365.12 ± 12.4132/28Salmon calcitoninBushenjiangufang ± salmon calcitoninVAS scoresEffectiveness rate6
25Zou [32], 201631/31Alendronate sodium tablets ± calcichew D3 tabletsBushenjiangutang ± alendronate sodium tablets ± calcichew D3 tabletsBMD of femoral neck and lumbar spine6
26Han [33], 201355.32 ± 1.5354.08 ± 3.2628/28Alfacalcidol soft capsules ± caltrateBushenzhuanggutang ± alfacalcidol soft capsules ± caltrateEffectiveness rate; adverse effects0/02
27Huang et al. [34], 201888/88Alendronate sodium tabletsBushentang ± alendronate sodium tabletsVAS scoresEffectiveness rate; BMD of femoral neck and lumbar spine; adverse effects0/06
28Huang et al. [35], 2017/—46/46Salmon calcitoninBushenhuoxuefang ± salmon calcitoninBMD of femoral neck and lumbar spine6
29Song et al. [36], 201576.1 ± 3.7876.4 ± 3.5690/90Salmon calcitoninBushenhuoxuefang ± salmon calcitoninEffectiveness rate; adverse effects0/012
30Pan and Ding [37], 201457. 2 ± 11. 256. 9 ± 11. 043/43Oyster shell calcium capsulesBushenhuoxuefang ± oyster shell calcium capsulesEffectiveness rate; BMD of femoral neck and lumbar spine; adverse effects0/43
31Wang [38], 201862.25 ± 5.0162.18 ± 4.58100/100Calcium carbonate and vitamin D3 tabletsBushenhuoxuetang ± calcium carbonate and vitamin D3 tabletsEffectiveness rate; BMD of lumbar spine3
32Gui et al. [39], 201766.28 ± 8.1766.19 ± 8.3430/30Alendronate sodium tablets ± caltrate DBushenyiqihuayutang ± alendronate sodium tablets ± caltrate DEffectiveness rate; BMD of total hip and lumbar spine; adverse effects4 Feb6
33Liu et al. [40], 2011 (2)59.8 ± 8.6Liu 2011 (2): 62.5 ± 9.7; Liu 2011 (2): 60.3 ± 10.2A: 45/45 B: 45Calcichew D3 tablesLiu 2011 (2): acupoint catgut embedding ± calcichew D3 tables; Liu 2011 (2): Xian Ling Gu Bao capsules ± calcichew D3 tablesTCM symptom integral; VAS scoresEffectiveness rate; BMD of lumbar spine6
34Ouyang et al. [46], 201165.6 ± 6.664.4 ± 5.325/30AlendronateAcupuncture and moxibustion ± alendronateTCM symptom integralBMD of lumbar spine and proximal femur6
35Zhou et al. [54], 201655 ± 456 ± 430/30Salmon calcitoninAcupoint injectionTCM symptom integralBMD of lumbar spine2
36Xie et al. [41], 201861.00 ± 3.1259.40 ± 4.1230/31Vitamin D chewable tablets ± calcitriol soft capsulesGushenfang ± vitamin D chewable tablets ± calcitriol soft capsulesEffectiveness rate; adverse effects0/03

Notes: the experimental group of Liu 2011 (1) was divided into 2 groups, respectively: Liu 2011 (1) and Liu 2011 (1); the experimental group of Liu 2011 (2) was divided into 2 groups, respectively: Liu 2011 (2) and Liu 2011 (2); the experimental group of Liu 2011 (3) was divided into 2 groups, respectively: Liu 2011 (3) and Liu 2011 (3). A: experimental group; B: control group.